Raras
Buscar doenças, sintomas, genes...
Osteodistrofia hereditária de Albright
ORPHA:665CID-10 · E20.1OMIM 612463DOENÇA RARA

Doença caracterizada por uma constelação de características clínicas denominadas coletivamente osteodistrofia hereditária de Albright (AHO), mas sem evidência de resistência ao hormônio da paratireóide (PTH), que é observada em outras formas de pseudo-hipoparatireoidismo (PHP).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença caracterizada por uma constelação de características clínicas denominadas coletivamente osteodistrofia hereditária de Albright (AHO), mas sem evidência de resistência ao hormônio da paratireóide (PTH), que é observada em outras formas de pseudo-hipoparatireoidismo (PHP).

Pesquisas ativas
4 ensaios
12 total registrados no ClinicalTrials.gov
Publicações científicas
284 artigos
Último publicado: 2026 Apr
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E20.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
7 sintomas
📏
Crescimento
4 sintomas
👁️
Olhos
2 sintomas
🦷
Dentes
2 sintomas
😀
Face
2 sintomas
🧠
Neurológico
2 sintomas

+ 10 sintomas em outras categorias

Características mais comuns

17%prev.
Deficiência intelectual
Ocasional (29-5%)
Baixa estatura
Bochechas cheias
Pescoço curto
Catarata
Nistagmo
29sintomas
Ocasional (1)
Sem dados (28)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 29 características clínicas mais associadas, ordenadas por frequência.

Deficiência intelectualIntellectual disability
Ocasional (29-5%)17%
Baixa estaturaShort stature
Bochechas cheiasFull cheeks
Pescoço curtoShort neck
CatarataCataract

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico284PubMed
Últimos 10 anos103publicações
Pico201713 papers
Linha do tempo
2026Hoje · 2026🧪 1997Primeiro ensaio clínico📈 2017Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

GNASProtein ALEXDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May inhibit the adenylyl cyclase-stimulating activity of guanine nucleotide-binding protein G(s) subunit alpha which is produced from the same locus in a different open reading frame

LOCALIZAÇÃO

Cell membraneCell projection, ruffle

VIAS BIOLÓGICAS (10)
G alpha (s) signalling eventsProstacyclin signalling through prostacyclin receptorADORA2B mediated anti-inflammatory cytokines productionGPER1 signalingG alpha (i) signalling events
EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
1324.4 TPM
Tireoide
727.3 TPM
Hipotálamo
548.6 TPM
Brain Frontal Cortex BA9
501.2 TPM
Cérebro - Hemisfério cerebelar
474.1 TPM
OUTRAS DOENÇAS (12)
progressive osseous heteroplasiapituitary adenoma 3, multiple typespseudohypoparathyroidism type 1CMcCune-Albright syndrome
HGNC:4392UniProt:P84996

Variantes genéticas (ClinVar)

467 variantes patogênicas registradas no ClinVar.

🧬 GNAS: NM_016592.5(GNAS):c.138C>A (p.Ala46=) ()
🧬 GNAS: NM_016592.5(GNAS):c.195del (p.Asn66fs) ()
🧬 GNAS: NM_000516.7(GNAS):c.177G>C (p.Gln59His) ()
🧬 GNAS: NM_000516.7(GNAS):c.-2_1del (p.Met1del) ()
🧬 GNAS: NM_000516.7(GNAS):c.516del (p.Ile172fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 10 variantes classificadas pelo ClinVar.

8
2
Patogênica (80.0%)
VUS (20.0%)
VARIANTES MAIS SIGNIFICATIVAS
GNAS: NM_000516.7(GNAS):c.27del (p.Glu10fs) [Pathogenic]
PDE4D: NM_001104631.2(PDE4D):c.671C>T (p.Thr224Ile) [Conflicting classifications of pathogenicity]
GNAS: NM_000516.7(GNAS):c.124C>G (p.Arg42Gly) [Likely pathogenic]
GNAS: NM_000516.7(GNAS):c.-1_2del (p.Met1del) [Pathogenic/Likely pathogenic]
GNAS: NM_000516.7(GNAS):c.575C>T (p.Pro192Leu) [Conflicting classifications of pathogenicity]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 24
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 8 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Osteodistrofia hereditária de Albright

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

2 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

12 ensaios clínicos encontrados, 4 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
107 papers (10 anos)
#1

Adult-onset pseudohypoparathyroidism type 1B diagnosed by methylation analysis: A case report and diagnostic considerations.

Medicine2026 Mar 13

Pseudohypoparathyroidism type 1B (PHP1B) is a rare endocrine disorder caused by epigenetic defects at the GNAS locus, leading to isolated renal resistance to parathyroid hormone (PTH). Although typically identified in childhood, adult-onset cases are uncommon and easily overlooked. This case highlights the diagnostic challenge of late-onset PHP1B and the critical role of methylation-specific testing. A 33-year-old man was referred for evaluation of incidentally detected hypocalcemia (serum calcium 5.9 mg/dL) during a routine health examination. He complained of mild paresthesia of the hands and eyelid twitching but had no family history of endocrine disorders and exhibited no phenotypic features of Albright hereditary osteodystrophy. Laboratory evaluation revealed persistent hypocalcemia (serum calcium 7.7 mg/dL) and markedly elevated PTH levels (284.2 pg/mL) despite correction of magnesium and vitamin D insufficiency. Standard sequencing of the GNAS and STX16 genes showed no pathogenic variants. However, methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) identified gain of methylation in the NESP55 region and loss of methylation in the AS, XL, and A/B differentially methylated regions confirming a diagnosis of sporadic PHP1B. The patient received oral calcium carbonate and cholecalciferol supplementation. Magnesium deficiency was corrected with oral magnesium oxide. The patient remained asymptomatic during follow-up with adequate calcium supplementation. Adult-onset PHP1B should be considered in the differential diagnosis of unexplained hypocalcemia with elevated PTH, even in the absence of Albright hereditary osteodystrophy. Because conventional sequencing cannot detect imprinting defects, epigenetic testing such as MS-MLPA is essential for definitive diagnosis. Increased awareness of atypical, late-onset presentations can aid in timely diagnosis and appropriate management.

#2

Cerebral Calcification and Treatment-Resistant Seizures: A Rare Syndromic Presentation of Pseudohypoparathyroidism-A Case Report.

AACE endocrinology and diabetes2026

Pseudohypoparathyroidism (PHP) has a varied presentation, ranging from biochemically detected hypocalcemia in asymptomatic individuals to treatment-refractory seizures. Features may develop over time. Hypocalcemia with recurrent seizures in adolescents indicates a cause other than a primary central nervous system cause, rather than hypoparathyroidism and pseudohypoparathyroidism being the endocrinological causes. We present a case of an adolescent girl with difficult-to-treat seizures and dystonic body movement whose diagnostic workup confirmed PHP. Phenotypically, she fit in Albright hereditary osteodystrophy. However, her hypothyroidism status and obesity are more in favor of PHP type 1a. After treatment with calcium and calcitriol, her symptoms and biochemical parameters improved. PHP is a rare disorder involving hormone resistance that disrupts calcium homeostasis, presenting with hypocalcemia, hyperphosphatemia, and high parathyroid hormone despite normal vitamin D3. Adolescents may solely present with seizures, which poses a diagnostic challenge. The basal ganglia calcification causing extrapyramidal symptoms should prompt evaluation for hypocalcemia and possible endocrine causes. PHP may be associated with Albright Hereditary Osteodystrophy, featuring short stature, obesity, brachydactyly, and low intelligence. PHP requires prompt diagnosis and treatment with calcium and calcitriol, which can fully reverse symptoms. This case emphasizes the importance of detecting PHP as a potential cause of treatment-refractory seizures in patients with hypocalcemia, underscoring timely management to prevent hypocalcemic complications and seizures.

#3

Three-generation familial transmission of a GNAS variant: from gestational phenotype in the mother to evolving prenatal/neonatal phenotype in the offspring.

Hormones (Athens, Greece)2026 Mar

Disorders caused by GNAS gene variants, including pseudohypoparathyroidism (PHP) types 1a, 1b and 1c, and pseudo-pseudohypoparathyroidism (PPHP), present with complex imprinting and phenotypic variability. The gene's parent-of-origin expression pattern results in diverse clinical manifestations. We report a three-generation family harboring a heterozygous missense variant in GNAS (c.305 C > T, p.Ala102Val), classified as "likely pathogenic". The proband, a 29-year-old primigravida, and her mother displayed phenotypic features of Albright hereditary osteodystrophy (AHO) including short stature, brachydactyly, round face, and obesity. The proband was diagnosed with primary hypothyroidism at age 25. During pregnancy, her hormonal profile resembled PPHP rather than PHP 1a, with normocalcemia and elevated parathyroid hormone (PTH), potentially masked by pregnancy physiology. Her mother's phenotype was consistent with PPHP and exhibited elevated PTH due to vitamin D deficiency. The proband delivered a male neonate with normal birth parameters, but was later found to carry the familial GNAS variant. The neonate developed features of AHO, elevated PTH, and transient hypothyroidism, consistent with PHP 1a. Hormonal and calcium homeostasis remained stable with supplementation. This is, to the best of our knowledge, the first reported case of a three-generation family with a GNAS variant demonstrating an evolving phenotype during pregnancy and early life. Pregnancy-related physiological changes may counteract typical hormone resistance, complicating diagnosis. Our findings emphasize the importance of genetic counseling and longitudinal follow-up in GNAS-related disorders, particularly during reproductive planning and early infancy.

#4

Sodium thiosulfate as a potential treatment for osteoma cutis in Albright hereditary osteodystrophy: A case report.

JAAD case reports2026 Apr
#5

Late-Onset Pseudohypoparathyroidism: A Case Report.

Cureus2025 Sep

Pseudohypoparathyroidism (PHP) is a rare endocrine disorder due to end-organ resistance to parathyroid hormone (PTH), resulting in hypocalcemia and hyperphosphatemia despite elevated PTH levels. It usually presents in children with distinctive features known as Albright Hereditary Osteodystrophy (AHO). We report a 33-year-old man who presented with wrist pain, muscle spasms, and tingling in his hands. Laboratory investigations revealed hypocalcemia, hyperphosphatemia, and elevated serum PTH, with normal serum magnesium, renal function, and vitamin D levels, suggestive of PTH resistance. The patient was managed with calcium and vitamin D supplementation. This case highlights the diagnostic challenges of adult-onset PHP in the absence of classical features of AHO and emphasizes the importance of recognizing biochemical patterns of PTH resistance. Timely diagnosis and management can lead to symptom resolution and prevent long-term complications, such as skeletal abnormalities, neurological symptoms, cataracts, and dental abnormalities.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC80 artigos no totalmostrando 103

2026

Sodium thiosulfate as a potential treatment for osteoma cutis in Albright hereditary osteodystrophy: A case report.

JAAD case reports
2026

Adult-onset pseudohypoparathyroidism type 1B diagnosed by methylation analysis: A case report and diagnostic considerations.

Medicine
2026

Cerebral Calcification and Treatment-Resistant Seizures: A Rare Syndromic Presentation of Pseudohypoparathyroidism-A Case Report.

AACE endocrinology and diabetes
2026

Three-generation familial transmission of a GNAS variant: from gestational phenotype in the mother to evolving prenatal/neonatal phenotype in the offspring.

Hormones (Athens, Greece)
2025

Late-Onset Pseudohypoparathyroidism: A Case Report.

Cureus
2025

Six cases of ectopic cutaneous ossification associated with GNAS gene variants.

European journal of dermatology : EJD
2025

Pseudohypoparathyroidism type 1B mimicking gitelman syndrome: diagnostic pitfalls and molecular insights.

Frontiers in genetics
2025

Pseudohypoparathyroidism with normocalcemia: a rare case report from Nepal.

Annals of medicine and surgery (2012)
2025

Clinical evaluation and molecular analysis of genetic and epigenetic inactivation defects in GNAS in children: A multicenter experience in China.

European journal of endocrinology
2025

Analysis of the prevalence and incidence of pseudohypoparathyroidism in Poland based on National Health Fund data with clinical presentation of own cases.

Frontiers in endocrinology
2025

Alpha-smooth muscle actin-expressing dermal sheath cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright hereditary osteodystrophy.

JBMR plus
2024

gnas Knockdown Induces Obesity and AHO Features in Early Zebrafish Larvae.

International journal of molecular sciences
2024

Case report: Familial hypoparathyroidism with elevated parathyroid hormone due to an inactivating PTH mutation.

Frontiers in endocrinology
2024

A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report.

Open life sciences
2024

STX16 exon 5-7 deletion in a patient with pseudohypoparathyroidism type 1B.

Journal of pediatric endocrinology & metabolism : JPEM
2024

Hair follicle-resident progenitor cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright hereditary osteodystrophy.

bioRxiv : the preprint server for biology
2024

Identification of a novel GNAS mutation in a family with pseudohypoparathyroidism type 1A.

BMC pediatrics
2024

Novel 4.18 Mb deletion resulting in 2q37 microdeletion syndrome combined with PTH resistance found in one Chinese patient.

Endocrine
2024

Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report.

Journal of pediatric endocrinology & metabolism : JPEM
2023

Rare Case of Pseudohypoparathyroidism With Normocalcemia Because of a Novel GNAS Mutation.

JCEM case reports
2023

Parathyroid Hormone Resistance: An Uncommon Cause of Hypocalcaemia in an Adult Ghanaian Female.

West African journal of medicine
2024

Clinical and Molecular Characteristics and Long-term Follow-up of Children With Pseudohypoparathyroidism Type IA.

The Journal of clinical endocrinology and metabolism
2023

GNAS gene mutations affecting XLαs and bone health: A long neglected relationship.

Clinical genetics
2023

Albright hereditary osteodystrophy: Delay in the diagnosis of a rare disorder due to restricted medical services.

Clinical case reports
2023

Atrophic macules containing mesenchymal cells are precursor lesions of osteoma cutis in Albright hereditary osteodystrophy.

Journal of cutaneous pathology
2023

Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development.

PloS one
2022

Complete Pseudo-Anodontia in an Adult Woman with Pseudo-Hypoparathyroidism Type 1a: A New Additional Nonclassical Feature?

Diagnostics (Basel, Switzerland)
2022

Genetics of Obesity in Humans: A Clinical Review.

International journal of molecular sciences
2022

2q37 deletion syndrome in a Colombian patient with macrocephaly: a case report.

BMC pediatrics
2022

Delayed diagnosis of pseudohypoparathyroidism type 1a with rare hypothyroidism since childhood.

Oxford medical case reports
2022

Different AHO phenotype in a Chinese family with a novel GNAS missense variant: a case report.

Italian journal of pediatrics
2022

Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance.

Frontiers in endocrinology
2022

Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.

Current osteoporosis reports
2022

A novel variant in the GNAS complex locus causes Albright hereditary osteodystrophy with pseudopseudohypoparathyroidism.

JAAD case reports
2022

A novel deletion involving the first GNAS exon encoding Gsα causes PHP1A without methylation changes at exon A/B.

Bone
2022

Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy.

JBMR plus
2021

Calcitriol and Levothyroxine Dosing for Patients With Pseudohypoparathyroidism.

Journal of the Endocrine Society
2022

Central Precocious Puberty in a Boy with Pseudohypoparathyroidism Type 1A due to a Novel GNAS Variant, with Congenital Hypothyroidism as the First Manifestation.

Journal of clinical research in pediatric endocrinology
2021

Subcutaneous Calcification and Fixed Flexion Deformity of the Right Elbow Joint in a Child with a GNAS Mutation: A Case Report.

International journal of endocrinology and metabolism
2021

Progressive Osseous Heteroplasia is not an Autosomal Dominant Trait but Reflects Superimposed Mosaicism in Different GNAS Inactivation Disorders.

Indian dermatology online journal
2021

Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications.

The Journal of clinical endocrinology and metabolism
2021

An intricate case of sporadic pseudohypoparathyroidism type 1B with a review of literature.

Archives of endocrinology and metabolism
2020

Imprinting disorders in humans: a review.

Current opinion in pediatrics
2020

Legg-Calve-Perthes disease in an 8-year old girl with Acrodysostosis type 1 on growth hormone therapy: case report.

International journal of pediatric endocrinology
2020

Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS.

Scientific reports
2020

Identification of a novel mutation in pseudohypoparathyroidism type Ia in a Chinese family: A case report.

Medicine
2020

A Novel Spindle Cell Population in a Case of Primary Osteoma Cutis With GNAS Mutation.

The American Journal of dermatopathology
2019

Hypocalcemic Recurrent Generalized Seizures with Bilateral Basal Ganglia and Frontal Calcification as the Initial Manifestation of Albright's Hereditary Osteodystrophy in a Child: A Pictorial and Video-graphic Representations.

Journal of pediatric neurosciences
2020

Dental and craniofacial features associated with GNAS loss of function mutations.

European journal of orthodontics
2019

2q37 Deletions in Patients With an Albright Hereditary Osteodystrophy Phenotype and PTH Resistance.

Frontiers in endocrinology
2019

Resistance to GHRH but Not to PTH in a 15-Year-Old Boy With Pseudohypoparathyroidism 1A.

Journal of the Endocrine Society
2019

A Case of Soft Tissue Ossifications: A Case Report.

JBJS case connector
2019

Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders.

American journal of medical genetics. Part A
2019

KBG syndrome presenting with brachydactyly type E.

Bone
2019

Hypercalcitoninaemia in pseudohypo-parathyroidism type 1A and type 1B.

Endocrinology, diabetes & metabolism case reports
2019

Language delay and developmental catch-up would be a clinical feature of pseudohypoparathyroidism type 1A during childhood.

Endocrine journal
2019

Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3.

Clinical epigenetics
2019

[Implication in Paediatrics of the First International Consensus Statement for the Diagnosis and management of pseudohypoparathyroidism and related disorders].

Anales de pediatria
2018

Brachydactyly Mental Retardation Syndrome Diagnosed in Adulthood.

Cureus
2018

Case report: An infantile lethal form of Albright hereditary osteodystrophy due to a GNAS mutation.

Clinical case reports
2018

Brachydactyly mental retardation syndrome with growth hormone deficiency.

Endocrinology, diabetes & metabolism case reports
2018

Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.

BMC medical genetics
2017

Case Report of a Satin Guinea Pig with Fibrous Osteodystrophy That Resembles Human Pseudohypoparathyroidism.

Case reports in veterinary medicine
2018

The stimulatory G protein Gsα is required in melanocortin 4 receptor-expressing cells for normal energy balance, thermogenesis, and glucose metabolism.

The Journal of biological chemistry
2018

Mosaicism for GNAS methylation defects associated with pseudohypoparathyroidism type 1B arose in early post-zygotic phases.

Clinical epigenetics
2017

Classic and Non-Classic Features in Pseudohypoparathyroidism: Case Study and Brief Literature Review.

Cureus
2018

(Epi)genotype-Phenotype Analysis in 69 Japanese Patients With Pseudohypoparathyroidism Type I.

Journal of the Endocrine Society
2017

Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.

Journal of clinical research in pediatric endocrinology
2018

Cognitive and behavioral phenotype of children with pseudohypoparathyroidism type 1A.

American journal of medical genetics. Part A
2018

Pseudohypoparathyroidism.

Minerva endocrinologica
2018

Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMI.

The Journal of clinical endocrinology and metabolism
2017

2q37 Deletion syndrome confirmed by high-resolution cytogenetic analysis.

Annals of pediatric endocrinology & metabolism
2017

Early-Onset Obesity: Unrecognized First Evidence for GNAS Mutations and Methylation Changes.

The Journal of clinical endocrinology and metabolism
2017

Isolated brachydactyly type E and idiopathic pancreatitis in a patient presenting to a lipid disorders clinic.

BMJ case reports
2017

Multiple miliary osteoma cutis of the face associated with Albright hereditary osteodystrophy in the setting of acne vulgaris: a case report.

Dermatology online journal
2017

A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gsα Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2017

Gsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations.

The Journal of clinical investigation
2017

Diffuse Symmetric Cerebral Calcifications: An Emerging Clinical Pivot.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2016

Sporadic pseudohypoparathyroidism type-1b with asymptomatic hypocalcemia.

Pediatrics international : official journal of the Japan Pediatric Society
2017

Nonclassic features of pseudohypoparathyroidism type 1A.

Current opinion in endocrinology, diabetes, and obesity
2016

Genetic and epigenetic alterations in the GNAS locus and clinical consequences in Pseudohypoparathyroidism: Italian common healthcare pathways adoption.

Italian journal of pediatrics
2017

Osteosarcoma in a Patient With Pseudohypoparathyroidism Type 1b Due to Paternal Uniparental Disomy of Chromosome 20q.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2016

[Genes in the cAMP pathway causing skeletal dysplasia with or without hormonal resistance].

Biologie aujourd'hui
2016

The Association of Pseudohypoparathyroidism Type Ia with Chiari Malformation Type I: A Coincidence or a Common Link?

Case reports in medicine
2016

Total Ankylosis of the Upper Left Limb: A Case of Progressive Osseous Heteroplasia.

The archives of bone and joint surgery
2017

Follow-up Findings in a Turkish Girl with Pseudohypoparathyroidism Type Ia Caused by a Novel Heterozygous Mutation in the GNAS Gene.

Journal of clinical research in pediatric endocrinology
2016

Macrosomia, obesity, and macrocephaly as first clinical presentation of PHP1b caused by STX16 deletion.

American journal of medical genetics. Part A
2016

Single Gene and Syndromic Causes of Obesity: Illustrative Examples.

Progress in molecular biology and translational science
2016

Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: A hypothesis.

European journal of medical genetics
2016

Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or Pseudohypoparathyroidism.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2016

Gsα Deficiency in the Ventromedial Hypothalamus Enhances Leptin Sensitivity and Improves Glucose Homeostasis in Mice on a High-Fat Diet.

Endocrinology
2015

Abnormal Methylation Status of the GNAS Exon 1A Region in Pseudohypohyperparathyroidism Combined With Turner Syndrome.

The American journal of the medical sciences
2015

A Girl With Beckwith-Wiedemann Syndrome and Pseudohypoparathyroidism Type 1B Due to Multiple Imprinting Defects.

The Journal of clinical endocrinology and metabolism
2015

2q37.3 Deletion Syndrome: Two Cases with Highly Distinctive Facial Phenotype, Discordant Association with Schizophrenic Psychosis, and Shared Deletion Breakpoint Region on 2q37.3.

Cytogenetic and genome research
2015

[Paternal GNAS mutations: Which phenotypes? What genetic counseling?].

Annales d'endocrinologie
2015

Pseudohypoparathyroidism type Ib in 2015.

Annales d'endocrinologie
2015

Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.

Journal of pediatric endocrinology & metabolism : JPEM
2015

Genetic and epigenetic defects at the GNAS locus cause different forms of pseudohypoparathyroidism.

Annales d'endocrinologie
2015

A positive genotype-phenotype correlation in a large cohort of patients with Pseudohypoparathyroidism Type Ia and Pseudo-pseudohypoparathyroidism and 33 newly identified mutations in the GNAS gene.

Molecular genetics & genomic medicine
2015

[Clinical and radiological findings in a case of pseudohypoparathyroidism type 1a. Albright hereditary osteodystrophy].

Anales de pediatria (Barcelona, Spain : 2003)
2015

Progressive osseous heteroplasia: diagnosis, treatment, and prognosis.

The application of clinical genetics
2015

A case report of a 14 year old male with pseudohypoparathyroidism associated with multiple hormonal resistance.

Indian journal of clinical biochemistry : IJCB
2015

Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms.

The Journal of clinical endocrinology and metabolism

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Osteodistrofia hereditária de Albright.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Osteodistrofia hereditária de Albright

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Adult-onset pseudohypoparathyroidism type 1B diagnosed by methylation analysis: A case report and diagnostic considerations.
    Medicine· 2026· PMID 41824862mais citado
  2. Cerebral Calcification and Treatment-Resistant Seizures: A Rare Syndromic Presentation of Pseudohypoparathyroidism-A Case Report.
    AACE endocrinology and diabetes· 2026· PMID 41641299mais citado
  3. Three-generation familial transmission of a GNAS variant: from gestational phenotype in the mother to evolving prenatal/neonatal phenotype in the offspring.
    Hormones (Athens, Greece)· 2026· PMID 41222894mais citado
  4. Sodium thiosulfate as a potential treatment for osteoma cutis in Albright hereditary osteodystrophy: A case report.
    JAAD case reports· 2026· PMID 41859426mais citado
  5. Late-Onset Pseudohypoparathyroidism: A Case Report.
    Cureus· 2025· PMID 41170251mais citado
  6. Pseudohypoparathyroidism in a Chinese girl: A case report.
    J Int Med Res· 2026· PMID 41968081recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:665(Orphanet)
  2. OMIM OMIM:612463(OMIM)
  3. MONDO:0012912(MONDO)
  4. GARD:7860(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q1477265(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Osteodistrofia hereditária de Albright
Compêndio · Raras BR

Osteodistrofia hereditária de Albright

ORPHA:665 · MONDO:0012912
CID-10
E20.1 · Pseudohipoparatireoidismo
Ensaios
4 ativos
MedGen
UMLS
C0033835
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades